Exelixis
EXEL
#1812
Rank
โ‚ฌ9.36 B
Marketcap
34,81ย โ‚ฌ
Share price
-1.23%
Change (1 day)
1.42%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

We have found no dividend yield history for this company